C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/078 (2010.01) C12N 5/071 (2010.01) A61K 35/12 (2006.01) A61K 35/28 (2006.01) A61P 9/00 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2709442
Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell populations which co-express CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.
Herring W. Joseph
Ho Tony W.
Kopen Gene C.
Ragaglia Vanessa
Righter William F.
Borden Ladner Gervais Llp
Garnet Biotherapeutics Inc.
LandOfFree
Cell populations which co-express cd49c and cd90 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell populations which co-express cd49c and cd90, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell populations which co-express cd49c and cd90 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1410723